Supernus Pharmaceuticals Inc
NASDAQ:SUPN

Watchlist Manager
Supernus Pharmaceuticals Inc Logo
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
Watchlist
Price: 36.18 USD -4.21% Market Closed
Market Cap: 2B USD
Have any thoughts about
Supernus Pharmaceuticals Inc?
Write Note

Supernus Pharmaceuticals Inc
PP&E Net

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Supernus Pharmaceuticals Inc
PP&E Net Peer Comparison

Comparables:
JNJ
BMY
PFE
MRK
LLY

Competitive PP&E Net Analysis
Latest Figures & CAGR of Competitors

Company PP&E Net CAGR 3Y CAGR 5Y CAGR 10Y
Supernus Pharmaceuticals Inc
NASDAQ:SUPN
PP&E Net
$38m
CAGR 3-Years
-7%
CAGR 5-Years
6%
CAGR 10-Years
31%
Johnson & Johnson
NYSE:JNJ
PP&E Net
$20.5B
CAGR 3-Years
3%
CAGR 5-Years
3%
CAGR 10-Years
3%
Bristol-Myers Squibb Co
NYSE:BMY
PP&E Net
$8.3B
CAGR 3-Years
6%
CAGR 5-Years
9%
CAGR 10-Years
7%
Pfizer Inc
NYSE:PFE
PP&E Net
$19B
CAGR 3-Years
10%
CAGR 5-Years
5%
CAGR 10-Years
5%
Merck & Co Inc
NYSE:MRK
PP&E Net
$23.4B
CAGR 3-Years
8%
CAGR 5-Years
9%
CAGR 10-Years
6%
Eli Lilly and Co
NYSE:LLY
PP&E Net
$16.2B
CAGR 3-Years
22%
CAGR 5-Years
14%
CAGR 10-Years
7%

See Also

What is Supernus Pharmaceuticals Inc's PP&E Net?
PP&E Net
38m USD

Based on the financial report for Sep 30, 2024, Supernus Pharmaceuticals Inc's PP&E Net amounts to 38m USD.

What is Supernus Pharmaceuticals Inc's PP&E Net growth rate?
PP&E Net CAGR 10Y
31%

Over the last year, the PP&E Net growth was -12%. The average annual PP&E Net growth rates for Supernus Pharmaceuticals Inc have been -7% over the past three years , 6% over the past five years , and 31% over the past ten years .

Back to Top